Low circulating 25-hydroxyvitamin D (25OHD) levels are a risk factor for acute respiratory infection (eg, bronchiolitis) in children. However, little is known about the relation of circulating 25OHD with the many downstream functional molecules in target organs-such as the airway-and with clinical outcomes. In this prospective multicenter study of infants (age <1 year) hospitalized with bronchiolitis, we measured serum 25OHD levels and profiled the metabolome of 144 nasopharyngeal airway samples. Among 254 metabolites identified, we defined a set of 20 metabolites that are related to lower serum 25OHD and higher vitamin D-binding protein levels.
| BACKGROUND
Bronchiolitis is a common acute respiratory infection (ARI) and the leading cause of hospitalizations in US infants. 1 Previous studies have investigated the role of vitamin D in bronchiolitis pathobiology because of its immune-modulating properties and likely role in lung development. 2 Indeed, 25-hydroxyvitamin D (25OHD) undergoes enzymatic conversion to its functionally active form (1,25- 2 Epidemiological studies have demonstrated associations of lower circulating 25OHD levels at birth or during infancy with higher risks of ARI, including bronchiolitis. [3] [4] [5] Additionally, recent individual participant data meta-analysis of 25 randomized controlled trials also showed protective effects of vitamin D supplementation against ARI among individuals with low baseline 25OHD levels. 6 Most of these studies have assessed the concentration of blood 25OHD directly in relation to disease processes. [3] [4] [5] [6] [7] 
| ME TH ODS
We analyzed the data from a multicenter prospective cohort study of infants hospitalized with bronchiolitis (severe bronchiolitis (Table S1 ) during the 2011-2014 winter seasons. Bronchiolitis was defined by the American Academy of Pediatrics guidelines.
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The institutional review board of each participating hospital approved the study. Written informed consent was obtained from the infant's parent or guardian.
In addition to the measurements of phenotypic data through structured interview and medical record review, we collected blood and nasopharyngeal airway samples within 24 hours of hospitalization using a standardized protocol. 9, 10 Serum total 25OHD
and DBP levels were quantified by immunoassays; serum free and bioavailable 25OHD levels were computed using previously validated formulas. 12 Respiratory viruses were tested using real-time For this study, we analyzed 144 infants who underwent metabolomic profiling of nasopharyngeal airway samples. These 144 infants had sufficient amount of nasopharyngeal airway sample for metabolome testing. To identify a subset of nasopharyngeal metabolites related to lower levels of circulating 25OHD (free, bioavailable, and total), we used sparse partial least squares (sPLS) regression with cross-validation and LASSO penalization minimizing overfitting. Next, to examine the associations of these selected nasopharyngeal metabolites with risks of PPV, we fit multivariable logistic regression and generalized linear mixed-effects models adjusting for age, sex, race/ethnicity, feeding status, weight at presentation, detected virus, free 25OHD level, and potential patient clustering within hospitals.
P-values were adjusted for multiple comparisons using the Benjamini-Hochberg false discovery rate (FDR) method. Analyses used R version 3.4.
| RESULTS
Of 144 infants with bronchiolitis in the analytic cohort, the median age was 3 months (IQR 1-6 months), 61% were male, and 17% underwent PPV during hospitalization. The median level of serum total 25OHD was 23.7 ng/mL (IQR 16.0-31.1 ng/mL) and that of free 25OHD was 10.0 pg/mL (IQR 7.5-15.0 pg/mL), with significant correlation between these levels (r = .66; P < .001; Fig- ure S1). While most patient characteristics were not significantly different by free 25OHD status (Table 1) , infants with lower free 25OH levels were more likely to be male, non-Hispanic White, and breastfed (all P < .05).
Metabolomic profiling of nasopharyngeal airway samples 
| DISCUSSION
In this multicenter study of infants with severe bronchiolitis, the levels of circulating vitamin D-related compounds were associated with differences in the nasopharyngeal airway metabolomic profile.
Specifically, from a total of 254 detected metabolites, we derived a set of 20 airway metabolites-a metabolomic signature-that was associated with lower serum 25OHD (free, bioavailable, and total) levels. Of these, 9 airway metabolites (eg, glycerophospholipids esterified with specific fatty acids, sphingolipids) were significantly associated with a higher risk of PPV use. To our knowledge, this is the first study that has investigated the interrelations between circulating vitamin D-related compounds, airway metabolome, and clinical outcomes in infants with bronchiolitis.
T Ever attended daycare 10 (14) 13 (18) .70
Sibling in the household
Mostly breastfed for the first 3 mo of age 45 (64) 27 (39) .004
Smoke exposure at home 5 (7) 11 (15) .21
Corticosteroid use before the index hospitalization 11 (16) 11 (15 Serum total 25OHD level was significantly associated with the risk of positive pressure ventilation (PPV) use (odds ratio per 1 ng/mL increase 0.94; 95% CI: 0.89-0.98; P = .005). In addition, younger age (P = .01) and lower weight at presentation (P = .007) were also associated with a higher risk of PPV use.
c Defined by having one or more positive values for allergen-specific IgE.
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In agreement with our findings, studies of children 13, 14 and adults [15] [16] [17] [18] with various conditions (eg, asthma, sepsis) have reported the relationship of lower 25OHD levels with unique blood and urine metabolomic profiles, particularly in lipids-a major component of cell membrane and molecular signaling. 8 For example, a nested study of 245 participants in a clinical trial reported that children exposed to lower in utero 25OHD levels had higher serum concentration of palmitate, stearate, linoleate, and arachidonate at age 3 years. 13 Cohort studies of adults in Germany and Finland also demonstrated inverse associations between serum 25OHD levels and these fatty acids. 15, 16 Palmitate and stearate are saturated fatty acids known to enhance inflammatory signaling. 13 Higher consumption of these saturated fats is linked to dyslipidemia, which is associated with allergic sensitization, airway obstruction, and childhood asthma. 19 Additionally, linoleate and arachidonate (x-6 polyunsaturated fatty acids) are a precursor of the arachidonic cascade that produces lipid mediators (eg, leukotrienes, prostaglandins) and plays a major role in airway inflammation. 8 Furthermore, emerging evidence has also shown that 1,25OH 2 D modulates metabolism of sphingolipids-signaling molecules involved in immune response and inflammation, which are related to airway diseases, including bronchiolitis 10 and asthma. 8 In addition to these proinflammatory lipids, in agreement with our data, cross-sectional studies also reported associations of alphahydroxyisovalerate-a branched-chain amino acid-in urine with respiratory syncytial virus ARI in children 14 and asthma in adults. 17 Furthermore, a cross-sectional study of adult patients with sepsis also found relations of low 25OHD and high 2-hydroxybutyrate-an organic acid-levels in the serum with higher mortality. 18 Our study is consistent with these prior studies showing 25OHD-metabolome (in blood or urine) associations and extends them by demonstrating the interrelations of circulating 25OHD, metabolome in the airway (the disease locus), and bronchiolitis severity in infants.
The current study has several potential limitations. First, the study was based on the nasopharyngeal samples that were measured <24 hours of hospitalization at a single time-point. Second, as with any observational study, the observed associations do not necessarily prove causality and might be explained by reverse cau- 
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